Psychometric Validation of the Simplified Chinese Version of FACT-Hep for Patients with Hepatocellular Carcinoma Based on Classical Test Theory and Generalizability Theory

Author:

Wan Chonghua1,Chen Ying2,Ma Wanrui1,Meng Qiong2,Li Gaofeng3,Cun Yingli3

Affiliation:

1. The First Dongguan Affiliated Hospital of Guangdong Medical University

2. Kunming Medical University

3. Yunnan Tumor Hospital

Abstract

Abstract Background: Quality of life (QOL) is now concerned worldwide in cancer clinical fields, with the specific scales for hepatocellular carcinoma patients in China being seldom and no formal validation of the Chinese Version of the FACT-Hep. Objective: This study was aimed to validate the Chinese FACT-Hep based on Combinations of Classical Test Theory and Generalizability Theory. Methods: 114 in-patients with hepatocellular carcinoma were measured three times before and after treatments using the FACT-Hep. The FACT-Hep was evaluated by indicators of Cronbach α, Pearson r, intra-class correlation (ICC), and standardized response mean. The Generalizability Theory was also applied to addresses the dependability of measurements deeply by estimation of multiple sources of variance. Results: The Cronbach’s α coefficients were greater than 0.70 for all domains, and test-retest reliability coefficients were greater than 0.80 (exception of EWB 0.74) with the range of 0.81-0.96. The domains of PWB, FWB and the overall scale had significant changes after treatments with SRM ranging from 0.40 to 0.69. G-coefficients and Ф-coefficients confirmed the reliability of the scale further with exact variance components. Conclusions: The Chinese version of FACT-Hep can be used to measure QOL for patients with hepatocellular carcinoma in China with good psychometric properties.

Publisher

Research Square Platform LLC

Reference35 articles.

1. Global cancer statistics, 2002;Parkin DM;CA Cancer J Clin,2005

2. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review;Fan SY;Clin Gastroenterol Hepatol,2010

3. An evaluation on incidence cases of liver cancer in China (in Chinese);Chen JG;Bull Chin Cancer,2005

4. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2008) Cancer statistics 2008. Retrieved April 14, 2008, from http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf.

5. Ferlay J, Bray F, Pisani P. (2001) Globocan 2000: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No.5 [DB/CD]. Lyon: IARC, 2001.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3